Abbott to Acquire Exact Sciences for $21B, Entering Cancer Diagnostics Leadership
Abbott Laboratories (NYSE: ABT) and Exact Sciences Corp. (NASDAQ: EXAS) announced a definitive agreement under...
Abbott Laboratories (NYSE: ABT) and Exact Sciences Corp. (NASDAQ: EXAS) announced a definitive agreement under...
Abbott Laboratories (NYSE: ABT) today released its financial results for the quarter ended September 30, 2025. For...
Abbott (NYSE: ABT) reported global sales of USD 11.14 billion for the second quarter of...
US-based health care firm Abbott (NYSE: ABT) this week entered into a partnership with the...
US-based medical device giant Abbott Laboratories (NYSE: ABT) announced that it has received marketing approval...
US-Irish firm Medtronic plc (NYSE: MDT) has submitted twin 510(k) applications to the U.S. Food...
US-based Abbott Laboratories (NYSE: ABT) has announced the receipt of the CE mark in the...
Recent days have seen significant leadership changes at two pharmaceutical giants: UK-based GSK plc (LON:...
US-based Abbott Laboratories (NYSE: ABT) has released its Q4 2024 financial results, reporting an 8.8%...
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic license agreement with Abbott...
US-based Abbott Laboratories (NYSE: ABT) has announced the successful application of its transcatheter aortic valve...
Abbott Laboratories (NYSE: ABT), a leading US healthcare company, has announced the opening of its...
Shenzhen-based vascular intervention specialist OrbusNeich Medical Group Ltd (HKG: 6929) has announced a significant distribution...
Abbott Laboratories (NYSE: ABT), a global healthcare giant based in the US, has reported its...
Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has announced the appointment of Zhu Tong as...
Abbott (NYSE: ABT), a global healthcare giant, has this week announced its financial results for...
AbbVie (NYSE: ABBV), a leading US pharmaceutical company, has announced that Rick González, who has...
US healthcare company Abbott (NYSE: ABT) has released its financial results for the fourth quarter...
Abbott (NYSE: ABT) has announced that the first patients have been treated with its Volt...
Abbott (NYSE: ABT) published its Q3 2023 financial results this week, reporting a 8.7% year-on-year...